CN114569843B - Nasal breathing device and rhinitis therapeutic instrument - Google Patents
Nasal breathing device and rhinitis therapeutic instrument Download PDFInfo
- Publication number
- CN114569843B CN114569843B CN202210129653.4A CN202210129653A CN114569843B CN 114569843 B CN114569843 B CN 114569843B CN 202210129653 A CN202210129653 A CN 202210129653A CN 114569843 B CN114569843 B CN 114569843B
- Authority
- CN
- China
- Prior art keywords
- nasal
- inner cylinder
- nasal cavity
- channel
- cylinder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000010352 nasal breathing Effects 0.000 title claims abstract description 30
- 206010039083 rhinitis Diseases 0.000 title claims abstract description 14
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 8
- 210000003928 nasal cavity Anatomy 0.000 claims abstract description 54
- 230000005540 biological transmission Effects 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 5
- 230000002411 adverse Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 7
- 230000029058 respiratory gaseous exchange Effects 0.000 description 5
- 238000009423 ventilation Methods 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 206010002653 Anosmia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 206010050515 Hyposmia Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 206010052437 Nasal discomfort Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000019559 hyposmia Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 208000037916 non-allergic rhinitis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000000015 thermotherapy Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
Abstract
The application discloses nasal breathing device and rhinitis therapeutic instrument includes: a gas delivery channel 1 and two double-layer cylinders 2 arranged side by side, wherein the tail ends of the double-layer cylinders 2 are used for aligning nostrils in use; the double-layered cylinder 2 includes an outer cylinder 21 and an inner cylinder 22, the inner cylinder 22 being located inside the outer cylinder 21; a nasal cavity air inlet channel 3 formed between the wall of the outer cylinder 21 and the wall of the inner cylinder 22 is communicated with the air inlet channel 1, the air inlet channel 1 is used for being connected with an air pipe of an external device, and air generated by the external device sequentially enters the nasal cavity through the air pipe, the air inlet channel 1 and the nasal cavity air inlet channel 3; the base 221 and the tip 222 of the inner cylinder 22 are both open, and the gas exhaled from the nasal cavity is discharged out of the nasal breathing device through the nasal exhalation passageways 4 formed by the inner cylinder 22. By adopting the nasal breathing device, the pollution of the expired air to the air transmission channel and the external device can be reduced, thereby reducing the adverse effect of the expired air from the nasal cavity on the treatment and the equipment.
Description
Technical Field
The application relates to the technical field of medical equipment, in particular to a nasal breathing device and a rhinitis therapeutic apparatus.
Background
The nose is an important organ of the human body, and is the main passage of air into the body, and is composed of the outer nose, nasal cavity and sinuses.
Rhinitis is a nasal mucosa inflammation caused by viruses, bacteria, allergens, various physicochemical factors and certain systemic diseases, and is pathologically classified into allergic (allergic) rhinitis and non-allergic rhinitis. Common symptoms of rhinitis include nasal obstruction, nasal itching, nasal discharge and sneeze, which are accompanied by complications such as hyposmia, throat itching, headache and the like, and severe cases can cause sphagitis, tracheitis, otitis media and asthma. Allergic rhinitis is accompanied by itching eyes, red, swelling and pain of nasal wings and nasal tips, etc.
Pharyngitis is nonspecific inflammation of pharynx, is a common name for inflammation caused by infection of pharynx by various microorganisms, and can exist alone, be concurrent with rhinitis, tonsillitis and laryngitis, or be a precursor symptom of some diseases. The clinic can be divided into acute pharyngitis and chronic pharyngitis. Typical symptoms include pharyngeal discomfort, pain, itching or dryness, burning sensation, smoking sensation, foreign body sensation, pharyngalgia, nausea, irritating cough, expectoration of secretions, severe cases with aversion to cold, high fever, headache, general discomfort, inappetence, dysphagia, dyspnea, and accompanying back and limb soreness, ear pain, tongue root lymphoid tissue inflammation, ear distress, tinnitus, and re-hearing.
The common cold is a common acute upper respiratory viral infectious disease, and is mostly caused by rhinoviruses, parainfluenza viruses, respiratory syncytial viruses, epstein-Barr viruses, coxsackie viruses, coronaviruses, adenoviruses and the like. Clinically, it is manifested as nasal obstruction, sneeze, watery nasal discharge, fever, cough, headache, etc.
The fumigation treatment of rhinitis by using a steam thermotherapy mode, pharyngitis and cold are important research directions in the non-drug treatment field, and a large number of clinical reports at home and abroad also prove that the fumigation treatment is a safe and effective physical therapy.
The nasal ventilation pipe or the ventilation cover is used for carrying out instrument ventilation, atomization treatment, humidification treatment, thermal therapy, auxiliary breathing and the like on the respiratory tract or other diseases, and at present, the existing nasal ventilation pipe or ventilation cover basically leads to inhalation and exhalation through the same channel, and the exhalation can influence the air pressure of a pipeline, influence the treatment effect and also can pollute the pipeline and a treatment host.
Disclosure of Invention
The embodiment of the application provides a nose breathing device and rhinitis therapeutic apparatus for solve the problem that the gas expired by the nasal cavity that exists among the prior art is great to the harmful effect that treatment and equipment produced.
Embodiments of the present application provide a nasal breathing device comprising:
a gas delivery channel 1 and two double-layered cylinders 2 arranged side by side, the ends of the double-layered cylinders 2 being arranged to be aligned with nostrils in use;
the double-layered cylinder 2 includes an outer cylinder 21 and an inner cylinder 22, the inner cylinder 22 being located inside the outer cylinder 21;
a nasal cavity air inlet channel 3 formed between the wall of the outer cylinder 21 and the wall of the inner cylinder 22 is communicated with the air inlet channel 1, the air inlet channel 1 is used for being connected with an air pipe of an external device, and air generated by the external device sequentially passes through the air pipe, the air inlet channel 1 and the nasal cavity air inlet channel 3 and enters a nasal cavity;
the base 221 and the tip 222 of the inner cylinder 22 are both open, and the gas exhaled from the nasal cavity is discharged outside the nasal breathing apparatus through the nasal exhalation passageways 4 formed by the inner cylinder 22.
Further, the gas transmission channel 1 is a slope channel, and the slope range of the slope channel is 30% -75%.
Further, the base end 211 of the outer cylinder 21 is gradually reduced toward the end 212, and the diameter ratio of the base end 211 to the end 212 is 3:2.
Further, the base end 221 of the inner cylinder 22 is gradually reduced toward the tip end 222, and the diameter ratio of the base end 221 to the tip end 222 is 3:2.
Further, the length of the outer cylinder 21 exceeds the length of the inner cylinder 22 by 10% -20%.
Further, the diameter ratio of the same vertical cross section of the outer cylinder 21 and the inner cylinder 22 is 2:5.
The embodiment of the application also provides a rhinitis therapeutic apparatus, which comprises: any of the nasal breathing devices described above.
The beneficial effects of the application include:
the nasal breathing device provided by the embodiment of the application comprises a gas transmission channel and two double-layer cylinders which are arranged side by side, wherein the tail ends of the double-layer cylinders are used for being aligned to nostrils in use; the double-layer cylinder comprises an outer cylinder and an inner cylinder, and the inner cylinder is positioned inside the outer cylinder; a nasal cavity air inlet channel formed between the wall of the outer cylinder and the wall of the inner cylinder is communicated with the air transmission channel, the air transmission channel is used for being connected with an air transmission pipeline of an external device, and air generated by the external device sequentially enters the nasal cavity through the air transmission pipeline, the air transmission channel and the nasal cavity air inlet channel; the base end and the tail end of the inner cylinder are both open, and the gas exhaled from the nasal cavity is discharged out of the nasal breathing device through the nasal cavity exhalation channel formed by the inner cylinder. In this nasal breathing apparatus, adopt the design of double-deck drum, set up the nasal cavity air inlet channel that is used for exclusively to the nostril gas transmission to and be used for the nasal cavity breathing passageway of the exhalant gas of discharge nasal cavity, through this binary channels design, can more effective discharge nasal cavity exhalant gas, reduce the exhalant gas that gets into the gas transmission passageway, also reduced the pollution of exhalant gas to gas transmission passageway and external device, thereby reduced the gas that the nasal cavity exhales to the bad influence that treatment and equipment produced.
Additional features and advantages of the application will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by practice of the application. The objectives and other advantages of the application will be realized and attained by the structure particularly pointed out in the written description and claims thereof as well as the appended drawings.
Drawings
The accompanying drawings are included to provide a further understanding of the application and are incorporated in and constitute a part of this specification, illustrate the application and together with the description serve to explain the embodiment of the application, and do not limit the application. In the drawings:
fig. 1 is a schematic perspective view of a nasal breathing apparatus according to an embodiment of the present disclosure;
FIG. 2 is a schematic cross-sectional view of a nasal breathing apparatus according to an embodiment of the present application;
fig. 3 is a schematic front view of the end of a double-layered cylinder of a nasal breathing apparatus according to an embodiment of the present application.
Detailed Description
In order to provide an implementation scheme for reducing adverse effects of nasal exhaled air on treatment and equipment, the embodiments of the present application provide a nasal breathing device and rhinitis treatment apparatus, and the following description of the preferred embodiments of the present application with reference to the accompanying drawings is to be understood that the preferred embodiments described herein are merely for illustration and explanation of the present application, and are not intended to limit the present application. And embodiments and features of embodiments in this application may be combined with each other without conflict.
Embodiments of the present application provide a nasal breathing apparatus, as shown in fig. 1-3, comprising: a gas delivery channel 1 and two double-layer cylinders 2 arranged side by side, wherein the tail ends of the double-layer cylinders 2 are used for aligning nostrils in use;
the double-layered cylinder 2 includes an outer cylinder 21 and an inner cylinder 22, the inner cylinder 22 being located inside the outer cylinder 21;
a nasal cavity air inlet channel 3 formed between the wall of the outer cylinder 21 and the wall of the inner cylinder 22 is communicated with the air inlet channel 1, the air inlet channel 1 is used for being connected with an air pipe of an external device, and air generated by the external device sequentially enters the nasal cavity through the air pipe, the air inlet channel 1 and the nasal cavity air inlet channel 3;
the base 221 and the tip 222 of the inner cylinder 22 are both open, and the gas exhaled from the nasal cavity is discharged out of the nasal breathing device through the nasal exhalation passageways 4 formed by the inner cylinder 22.
The above-mentioned nose breathing apparatus that this embodiment provided adopts the design of double-deck drum, has set up the nasal cavity air inlet channel that is used for specially to the nostril gas transmission to and be used for the nasal cavity breathing channel of the exhalant gas of discharge nasal cavity specially, through the design of this binary channels, can more effectual exhaust nasal cavity exhalant gas, reduce the exhalant gas that gets into gas transmission channel, also reduced the pollution of exhalant gas to gas transmission channel and external device, thereby reduced the gas that the nasal cavity exhales to the bad influence that treatment and equipment produced.
In the nasal breathing apparatus, an annular space is formed between the wall of the outer cylinder 21 and the wall of the inner cylinder 22, and is communicated with the gas delivery passage 1, as the nasal cavity gas inlet passage 3, the passage space formed by the inner cylinder 22 is used as the nasal cavity gas outlet passage 4, and both the base end 221 and the tip end 222 of the inner cylinder 22 are opened, that is, both ends are opened, and the nasal cavity gas inlet passage 3 and the nasal cavity gas outlet passage 4 are different passages. In the process of using the nasal breathing device, the tail ends of the two double-layer cylinders 2 are aligned to nostrils, gas (hot steam, atomized steam and the like) generated by an external device enters the gas transmission channel 1 through the channel inlet 5 of the gas transmission channel 1, and enters the nasal cavity in a spiral flow state in the nasal cavity air inlet channel 3 of the annular space after passing through the gas transmission channel 1, and as the two ends of the nasal cavity air outlet channel 4 are opened, the gas exhaled by the nasal cavity can be discharged out of the nasal breathing device through the nasal cavity air outlet channel 4 formed by the inner cylinder 22, and the gas exhaled by the nasal cavity basically does not enter the gas transmission channel through the nasal cavity air inlet channel and does not enter the external device (such as a treatment host), so bacteria and viruses carried by the gas exhaled by the nasal cavity can be effectively reduced, and the accumulation and breeding in each channel of the treatment host can be effectively reduced, and the treatment effect can be further improved.
In one embodiment of the present application, further, the gas delivery channel 1 may be a slope channel, and its slope range may be 30% -75%, and by adopting the design of the slope channel, the gas may be guided to more smoothly enter the outlet of the gas delivery channel 1 and enter the nasal cavity air inlet channel 3.
In one embodiment of the present application, further, the base end 211 of the outer cylinder 21 is tapered toward the tip end 212, and the diameter ratio of the base end 211 and the tip end 212 of the outer cylinder 21 is 3:2.
In one embodiment of the present application, further, the base end 221 of the inner cylinder 22 is tapered toward the tip end 222, and the diameter ratio of the base end 221 and the tip end 222 of the inner cylinder 22 is 3:2.
The diameters of the outer cylinder 21 and the inner cylinder 22 are gradually reduced from the base end to the tail end, so that the gas can form certain pressure after entering the nasal cavity air inlet channel 3, and the gas can enter the deep part of the nasal cavity more easily, thereby exerting better treatment effect.
In one embodiment of the present application, further, the length of outer cylinder 21 exceeds the length of inner cylinder 22 by 10% -20%. Since the inner cylinder 22 and the outer cylinder 21 are coaxial and the tip 222 of the inner cylinder 22 is shorter than the tip 212 of the outer cylinder 21, even when the gas in the annular nasal cavity intake passage 3 stops being generated for some reason, it can be returned into the inner cylinder 22 from the opening of the tip 222 of the inner cylinder 22 and discharged to the outside from the opening of the base end 221 of the inner cylinder 22 after reaching the tip 212 of the outer cylinder 21. That is, even when the injection of the gas is stopped, the gas itself continues to flow, thereby preventing accumulation in the nasal cavity intake passage 3, and the gas continues to flow, avoiding rising to a higher temperature, and also preventing a large amount of gas from being blown out at one time.
In one embodiment of the present application, further, the diameter ratio of the same vertical cross section of the outer cylinder 21 and the inner cylinder 22 may be 2:5.
The embodiment of the application also provides a rhinitis therapeutic apparatus, which comprises: any of the nasal breathing devices described above.
It is noted that relational terms such as first and second, and the like are used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Moreover, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising one … …" does not exclude the presence of other like elements in a process, method, article, or apparatus that comprises the element.
It will be apparent to those skilled in the art that various modifications and variations can be made in the present application without departing from the spirit or scope of the application. Thus, if such modifications and variations of the present application fall within the scope of the claims and the equivalents thereof, the present application is intended to cover such modifications and variations.
Claims (7)
1. A nasal breathing apparatus, comprising:
a gas delivery channel (1) and two double-layer cylinders (2) arranged side by side, wherein the ends of the double-layer cylinders (2) are used for aligning nostrils in use;
the double-layer cylinder (2) comprises an outer cylinder (21) and an inner cylinder (22), the inner cylinder (22) being located within the outer cylinder (21);
an annular space is formed between the cylinder wall of the outer cylinder (21) and the cylinder wall of the inner cylinder (22) and is used as a nasal cavity air inlet channel (3), the nasal cavity air inlet channel (3) is communicated with the air delivery channel (1), the air delivery channel (1) is used for being connected with an air delivery pipeline of an external device, and air generated by the external device sequentially passes through the air delivery pipeline, the air delivery channel (1) and the nasal cavity air inlet channel (3) and enters a nasal cavity;
the base end (221) and the tail end (222) of the inner cylinder (22) are both open, the space formed by the inner cylinder (22) is used as a nasal cavity exhalation channel (4), and the gas exhaled by the nasal cavity is discharged out of the nasal breathing device through the nasal cavity exhalation channel (4) formed by the inner cylinder (22).
2. Nasal breathing apparatus according to claim 1, wherein the gas delivery channel (1) is a ramp channel with a slope in the range of 30% -75%.
3. The nasal breathing device according to claim 1, wherein the base end (211) of the outer cylinder (21) tapers towards the tip end (212), the ratio of the diameters of the base end (211) and the tip end (212) being 3:2.
4. A nasal breathing device according to claim 3, wherein the base end (221) of the inner cylinder (22) tapers towards the tip end (222), the ratio of the diameters of the base end (221) and the tip end (222) being 3:2.
5. Nasal breathing device according to claim 1, wherein the length of the outer cylinder (21) exceeds the length of the inner cylinder (22) by 10% -20%.
6. Nasal breathing device according to claim 1, wherein the diameter ratio of the same vertical cross section of the outer cylinder (21) and the inner cylinder (22) is 2:5.
7. A rhinitis therapeutic apparatus, comprising: the nasal breathing device of any of claims 1-6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210129653.4A CN114569843B (en) | 2022-02-11 | 2022-02-11 | Nasal breathing device and rhinitis therapeutic instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210129653.4A CN114569843B (en) | 2022-02-11 | 2022-02-11 | Nasal breathing device and rhinitis therapeutic instrument |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114569843A CN114569843A (en) | 2022-06-03 |
| CN114569843B true CN114569843B (en) | 2024-02-02 |
Family
ID=81770485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210129653.4A Active CN114569843B (en) | 2022-02-11 | 2022-02-11 | Nasal breathing device and rhinitis therapeutic instrument |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114569843B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2395909A (en) * | 2001-09-06 | 2004-06-09 | Optinose As | Breath-actuated nasal delivery device |
| CN1981886A (en) * | 2001-06-12 | 2007-06-20 | 奥普蒂诺斯公司 | Nasal delivery devices |
| CN106074925A (en) * | 2016-06-03 | 2016-11-09 | 李美欢 | A kind of respiration health medicine and support the use device |
| CN110958898A (en) * | 2017-05-04 | 2020-04-03 | 3M创新有限公司 | Inhaler flow control mechanism |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0121568D0 (en) * | 2001-09-06 | 2001-10-24 | Optinose As | Nasal delivery device |
| US11471618B2 (en) * | 2014-11-09 | 2022-10-18 | Sipnose Ltd. | Adjustable dosing delivery and multi sectioned drug compartment |
-
2022
- 2022-02-11 CN CN202210129653.4A patent/CN114569843B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1981886A (en) * | 2001-06-12 | 2007-06-20 | 奥普蒂诺斯公司 | Nasal delivery devices |
| GB2395909A (en) * | 2001-09-06 | 2004-06-09 | Optinose As | Breath-actuated nasal delivery device |
| CN106074925A (en) * | 2016-06-03 | 2016-11-09 | 李美欢 | A kind of respiration health medicine and support the use device |
| CN110958898A (en) * | 2017-05-04 | 2020-04-03 | 3M创新有限公司 | Inhaler flow control mechanism |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114569843A (en) | 2022-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080223375A1 (en) | Single nasal prong nasal cannula | |
| CN208823711U (en) | A high-frequency ventilator oxygen delivery humidification device | |
| CN114569843B (en) | Nasal breathing device and rhinitis therapeutic instrument | |
| CN102274564A (en) | Colloidal particle controlled targeted pneumatic atomizing administration device | |
| CN217119086U (en) | A special oxygen inhalation humidification device for severe tracheotomy patients | |
| CN220938525U (en) | Atomized gas heating device and therapeutic instrument | |
| CN205494609U (en) | Breathing machine face guard with oxygen atomizing device | |
| CN107158539A (en) | A kind of high gas flow flow velocity prevents the nasopharyngeal air duct of nasal mucosa damage | |
| CN114602017A (en) | Nozzle for inhaler and inhaler | |
| CN107308532A (en) | Oropharyngeal airway with closed airbag | |
| CN201643301U (en) | An embedded multi-cavity diamond-shaped tube type endotracheal tube | |
| CN201189347Y (en) | Coaxial double-loop respirator | |
| CN221130645U (en) | Lung clearance device | |
| CN208525606U (en) | Expansion support type nasopharynx air duct | |
| WO2020001618A1 (en) | Nasopharynx stent for stopping snoring | |
| CN215938643U (en) | Pipeline heat exchange breathing equipment | |
| CN221535274U (en) | Dual-purpose adapter for tracheal catheter | |
| CN222533867U (en) | High-flow oxygen inhalation connector suitable for metal autogenous cutting sleeves of different types | |
| CN109011079A (en) | A kind of transnasal trachea catheter (double cuff) | |
| CN221470629U (en) | Novel trachea cannula | |
| CN211486097U (en) | Polytypic autogenous cutting sleeve pipe external diameter connecting piece | |
| CN210992336U (en) | multifunctional atomizer | |
| CN221358084U (en) | A ventilator pipeline and a ventilator | |
| CN201445687U (en) | High pressure oxygen injector | |
| CN221243681U (en) | Noninvasive ventilator multifunctional mask |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |